Gabapentin in the management of dysautonomia following severe traumatic brain injury: a case series
- PMID: 17435191
- PMCID: PMC2117822
- DOI: 10.1136/jnnp.2006.096388
Gabapentin in the management of dysautonomia following severe traumatic brain injury: a case series
Abstract
The pharmacological management of dysautonomia, otherwise known as autonomic storms, following acute neurological insults, is problematic and remains poorly researched. This paper presents six subjects with dysautonomia following extremely severe traumatic brain injury where gabapentin controlled paroxysmal autonomic changes and posturing in the early post-acute phase following limited success with conventional medication regimens. In two subjects, other medications were reduced or ceased without a recurrence of symptoms. It is proposed that medications that can block or minimise abnormal afferent stimuli may represent a better option for dysautonomia management than drugs which increase inhibition of efferent pathways. Potential mechanisms for these effects are discussed.
Conflict of interest statement
Competing interests: None.
References
-
- Sandel M E, Abrams P L, Horn L J. Hypertension after brain injury: case report. Arch Phys Med Rehabil 198667469–472. - PubMed
-
- Russo R N, O'Flaherty S. Bromocriptine for the management of autonomic dysfunction after severe traumatic brain injury. J Paediatr Child Health 200036283–285. - PubMed
-
- Cuny E, Richer E, Castel J P. Dysautonomia syndrome in the acute recovery phase after traumatic brain injury: relief with intrathecal baclofen therapy. Brain Inj 200115917–925. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical